Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9667855rdf:typepubmed:Citationlld:pubmed
pubmed-article:9667855lifeskim:mentionsumls-concept:C0037083lld:lifeskim
pubmed-article:9667855lifeskim:mentionsumls-concept:C0033681lld:lifeskim
pubmed-article:9667855lifeskim:mentionsumls-concept:C1704675lld:lifeskim
pubmed-article:9667855lifeskim:mentionsumls-concept:C1518827lld:lifeskim
pubmed-article:9667855pubmed:issue2lld:pubmed
pubmed-article:9667855pubmed:dateCreated1998-9-10lld:pubmed
pubmed-article:9667855pubmed:abstractTextProteins with SH2 or phosphotyrosine binding (PTB) domains bind activated tyrosine kinase receptors and their substrates to propagate signals into cells. Both of the domains recognize phosphotyrosine. Selectivity in these interactions is conferred by short flanking peptide motifs. Therefore, potential exists for modulating tyrosine kinase signaling pathways by the discovery of compounds that selectively bind SH2 and PTB domains. Recent advances with small peptides and nonpeptide compounds suggest that this opportunity can be realized.lld:pubmed
pubmed-article:9667855pubmed:languageenglld:pubmed
pubmed-article:9667855pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9667855pubmed:citationSubsetIMlld:pubmed
pubmed-article:9667855pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9667855pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9667855pubmed:statusMEDLINElld:pubmed
pubmed-article:9667855pubmed:monthAuglld:pubmed
pubmed-article:9667855pubmed:issn1367-5931lld:pubmed
pubmed-article:9667855pubmed:authorpubmed-author:ShoelsonS ESElld:pubmed
pubmed-article:9667855pubmed:issnTypePrintlld:pubmed
pubmed-article:9667855pubmed:volume1lld:pubmed
pubmed-article:9667855pubmed:ownerNLMlld:pubmed
pubmed-article:9667855pubmed:authorsCompleteYlld:pubmed
pubmed-article:9667855pubmed:pagination227-34lld:pubmed
pubmed-article:9667855pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:9667855pubmed:meshHeadingpubmed-meshheading:9667855-...lld:pubmed
pubmed-article:9667855pubmed:meshHeadingpubmed-meshheading:9667855-...lld:pubmed
pubmed-article:9667855pubmed:meshHeadingpubmed-meshheading:9667855-...lld:pubmed
pubmed-article:9667855pubmed:meshHeadingpubmed-meshheading:9667855-...lld:pubmed
pubmed-article:9667855pubmed:meshHeadingpubmed-meshheading:9667855-...lld:pubmed
pubmed-article:9667855pubmed:meshHeadingpubmed-meshheading:9667855-...lld:pubmed
pubmed-article:9667855pubmed:meshHeadingpubmed-meshheading:9667855-...lld:pubmed
pubmed-article:9667855pubmed:year1997lld:pubmed
pubmed-article:9667855pubmed:articleTitleSH2 and PTB domain interactions in tyrosine kinase signal transduction.lld:pubmed
pubmed-article:9667855pubmed:affiliationDepartment of Medicine, Harvard Medical School and Joslin Diabetes Center, 1 Joslin Place, Boston, MA 02215, USA. Shoelson@joslab.harvard.edulld:pubmed
pubmed-article:9667855pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9667855pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:9667855pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:9667855pubmed:publicationTypeReviewlld:pubmed
pubmed-article:9667855pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9667855lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9667855lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9667855lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9667855lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9667855lld:pubmed